The Netherlands confirmed it plans to divest its 33% stake in Urenco Limited. The U.K. government also owns a third of the company, while E.ON SE (DB:EOAN) and RWE AG (DB:RWE) hold equal shares of the remainder. The Netherlands was the only shareholder that hadn't yet disclosed its plan to sell its stake in the company. The Netherlands is currently in talks with the other shareholders about shaping the sale process, Finance Minister Jeroen Dijsselbloem said. He said Urenco is expected to generate "positive interest" from potential buyers, but that a sale can only take place if the public interest is safeguarded. The value of the whole company could be between €8 billion and €12 billion, people familiar with the matter told The Wall Street Journal in March 2013. The possible buyers of the firm include Cameco Corporation (TSX:CCO) and Areva S.A. (ENXTPA:AREVA).

Areva S.A. held its extraordinary general meeting of shareholders on May 7, 2013. In the meeting, shareholders of the company appointed the new college auditors with notably the appointment of Ernst & Young for a period of six fiscal years.

Areva S.A. held its extraordinary general meeting of shareholders on May 7, 2013. In the meeting, shareholders of the company approved the transfer of the group's head office to the Tour AREVA in Paris-La Défense in order to gather management teams in a single Paris-based location.